Haoyang Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Haoyang Hu has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Fei Yang
The First Medical Center, Chinese PLA General Hospital, Beijing, China
5 shared publicationsDengfa Zhao
Department of Neurology, The First Medical Center, Chinese PLA General Hospital, Beijing, China
2 shared publications- Fei Yang
Department of Neurology, The First Medical Center, Chinese PLA General Hospital, China
2 shared publications - Fei Yang
The First Medical Center, Chinese PLA General Hospital Beijing China
2 shared publications Hong Zhao
The First Medical Center, Chinese PLA General Hospital Beijing China
2 shared publications- Hong Zhao
The First Medical Center, Chinese PLA General Hospital Beijing China
2 shared publications
Latest Publications
- 1 November 2026
- Published by Radiological Society of North America (RSNA) in Radiology: Artificial Intelligence
- Vol. 8 (6) , e260801
From Per-Examination Savings to Project-level Breakeven in Expert-guided Segmentation
- 1 November 2026
- Published by Radiological Society of North America (RSNA) in Radiology: Artificial Intelligence
- Vol. 8 (6) , e260801
From Per-Examination Savings to Project-level Breakeven in Expert-guided Segmentation
- Open Access
- 23 October 2026
- Published by Wiley in Clinical Cardiology
- Vol. 49 (10) , e70505
Regional Heterogeneity in Ischemic Heart Disease and Ischemic Stroke Burden in Europe, 1990–2023: GBD 2023 and Complementary Mendelian Randomization Evidence
Background: Ischemic heart disease (IHD) and ischemic stroke (IS) remain major contributors to health loss in Europe, with regional heterogeneity. Comparisons of burden, attributable risks, and genetic evidence remain limited. Methods: Global Burden of Disease (GBD) 2023 estimates for Central, Eastern, and Western Europe from 1990 to 2023 were analyzed. Age‐standardized prevalence, incidence, mortality, and disability‐adjusted life‐year rates were summarized; temporal trends were assessed by Joinpoint regression and 2023 cross‐country concordance by Spearman correlation. GBD risk profiles were compared between 1990 and 2023. Complementary Mendelian randomization (MR) evaluated high blood pressure, fasting glucose, and low‐density lipoprotein cholesterol (LDL‐C). Results: Eastern Europe had the highest 2023 burden. IHD and IS rates were positively concordant across countries (Spearman ρ = 0.681–0.820; all p < 0.001), and regional 1990–2023 average annual percent changes were negative. High systolic blood pressure and high LDL‐C remained leading GBD‐attributable risks. In MR, genetic liability to high blood pressure was associated with IHD (odds ratio [OR] = 1.354, 95% confidence interval [CI] 1.281–1.433) and IS (OR = 1.351, 95% CI 1.295–1.409), and LDL‐C with IHD (OR = 1.610, 95% CI 1.508–1.719); these met the Bonferroni threshold. Fasting glucose showed nominal evidence for IHD, whereas fasting glucose and LDL‐C showed no statistically significant associations with overall IS. Conclusions: IHD and IS burdens declined across Europe, but regional inequalities persisted. GBD attribution and MR provide complementary evidence; cardiometabolic risks remain central, while genetic associations differ between IHD and overall IS.
- 23 October 2026
- Published by Wiley in Clinical Cardiology
- Vol. 49 (10) , e70505
Open AccessRegional Heterogeneity in Ischemic Heart Disease and Ischemic Stroke Burden in Europe, 1990–2023: GBD 2023 and Complementary Mendelian Randomization Evidence
Background: Ischemic heart disease (IHD) and ischemic stroke (IS) remain major contributors to health loss in Europe, with regional heterogeneity. Comparisons of burden, attributable risks, and genetic evidence remain limited. Methods: Global Burden of Disease (GBD) 2023 estimates for Central, Eastern, and Western Europe from 1990 to 2023 were analyzed. Age‐standardized prevalence, incidence, mortality, and disability‐adjusted life‐year rates were summarized; temporal trends were assessed by Joinpoint regression and 2023 cross‐country concordance by Spearman correlation. GBD risk profiles were compared between 1990 and 2023. Complementary Mendelian randomization (MR) evaluated high blood pressure, fasting glucose, and low‐density lipoprotein cholesterol (LDL‐C). Results: Eastern Europe had the highest 2023 burden. IHD and IS rates were positively concordant across countries (Spearman ρ = 0.681–0.820; all p < 0.001), and regional 1990–2023 average annual percent changes were negative. High systolic blood pressure and high LDL‐C remained leading GBD‐attributable risks. In MR, genetic liability to high blood pressure was associated with IHD (odds ratio [OR] = 1.354, 95% confidence interval [CI] 1.281–1.433) and IS (OR = 1.351, 95% CI 1.295–1.409), and LDL‐C with IHD (OR = 1.610, 95% CI 1.508–1.719); these met the Bonferroni threshold. Fasting glucose showed nominal evidence for IHD, whereas fasting glucose and LDL‐C showed no statistically significant associations with overall IS. Conclusions: IHD and IS burdens declined across Europe, but regional inequalities persisted. GBD attribution and MR provide complementary evidence; cardiometabolic risks remain central, while genetic associations differ between IHD and overall IS.
- Open Access
- 6 October 2026
- Published by Elsevier in JACC: Asia
- Vol. 6 (10) , 2436
Temporal Trends Should Not Be Interpreted as Intervention Effects
- 6 October 2026
- Published by Elsevier in JACC: Asia
- Vol. 6 (10) , 2436
Open AccessTemporal Trends Should Not Be Interpreted as Intervention Effects
- Open Access
- 5 October 2026
- Published by Springer Nature in Critical Care
- Vol. 30 (1) , 510
Assessing fluid responsiveness in intra-abdominal hypertension: a pressure difference is not yet a vascular zone
- 5 October 2026
- Published by Springer Nature in Critical Care
- Vol. 30 (1) , 510
Open AccessAssessing fluid responsiveness in intra-abdominal hypertension: a pressure difference is not yet a vascular zone
- 27 September 2026
- Published by Elsevier in Journal of Pain and Symptom Management
From Conditions to People: Multimorbidity in SeriousHealth-Related Suffering Estimates
- 27 September 2026
- Published by Elsevier in Journal of Pain and Symptom Management
From Conditions to People: Multimorbidity in SeriousHealth-Related Suffering Estimates
- 25 September 2026
- Published by Elsevier in British Journal of Anaesthesia
Functional impairment in patients undergoing major orthopaedic surgery under general anaesthesia with or without regional anaesthesia: clarifying the estimand when discharge determines measurement. Comment on Br J Anaesth 2026; 137: 849–57
- 25 September 2026
- Published by Elsevier in British Journal of Anaesthesia
Functional impairment in patients undergoing major orthopaedic surgery under general anaesthesia with or without regional anaesthesia: clarifying the estimand when discharge determines measurement. Comment on Br J Anaesth 2026; 137: 849–57
- Open Access
- 6 September 2026
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1)
Burden dynamics of pulmonary arterial hypertension in China and the G20 aggregate: a comparative analysis based on the global burden of disease study 2023
Pulmonary arterial hypertension (PAH) is a progressive and life-threatening pulmonary vascular disease characterized by increased pulmonary vascular resistance and pulmonary arterial pressure, whic...
- 6 September 2026
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1)
Open AccessBurden dynamics of pulmonary arterial hypertension in China and the G20 aggregate: a comparative analysis based on the global burden of disease study 2023
Pulmonary arterial hypertension (PAH) is a progressive and life-threatening pulmonary vascular disease characterized by increased pulmonary vascular resistance and pulmonary arterial pressure, whic...
- 31 August 2026
- Published by Elsevier in Sleep Health
Does the age interaction reflect underweight—or a changing insomnia phenotype?
- 31 August 2026
- Published by Elsevier in Sleep Health
Does the age interaction reflect underweight—or a changing insomnia phenotype?
- Open Access
- 19 August 2026
- Published by SAGE Publications in Cephalalgia
- Vol. 46 (8)
Baseline severity is not treatment timing in acute rimegepant treatment for vestibular migraine
- 19 August 2026
- Published by SAGE Publications in Cephalalgia
- Vol. 46 (8)
Open AccessBaseline severity is not treatment timing in acute rimegepant treatment for vestibular migraine
- 30 July 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (8) , 662
Reconsidering the non-obese phenotype of idiopathic intracranial hypertension
- 30 July 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (8) , 662
Reconsidering the non-obese phenotype of idiopathic intracranial hypertension